Literature DB >> 22341978

Abnormal spinal cord pain processing in Huntington's disease. The role of the diffuse noxious inhibitory control.

Armando Perrotta1, Claudia Serpino, Claudia Cormio, Mariano Serrao, Giorgio Sandrini, Francesco Pierelli, Marina de Tommaso.   

Abstract

OBJECTIVES: Our study is aimed to evaluate the spinal cord pain processing in Huntington's disease (HD) by testing both the temporal summation threshold (TST) of the nociceptive withdrawal reflex (NWR) and the functional activity of the diffuse noxious inhibitory control (DNIC) as form of supraspinal control of pain.
METHODS: We enrolled 19 HD patients and 17 healthy controls. We measured threshold (Th), Area, TST and related psychophysical pain sensations of the NWR, at baseline and during and after activation of the DNIC by means of cold pressor test (CPT) as heterotopic noxious conditioning stimulation.
RESULTS: In HD patients we found a significantly higher Th and TST as well as a lower Area when compared to controls. During the CPT, a significant inhibition of reflex and psychophysical pain responses were found in both HD patients and controls when compared to baseline, without differences between the groups in CPT results.
CONCLUSIONS: Our study demonstrated an abnormal spinal cord pain processing in HD patients. Abnormalities in pain processing are not apparently linked to a dysfunctional DNIC inhibitory projection system in HD patients. SIGNIFICANCE: Our findings support the hypothesis that the striatum could play a role in pain modulation and that its atrophy could affect pain processing without change the DNIC efficiency.
Copyright © 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341978     DOI: 10.1016/j.clinph.2012.01.012

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  5 in total

Review 1.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

2.  Lower Prevalence of Chronic Pain in Manifest Huntington's Disease: A Pilot Observational Study.

Authors:  Marianna Delussi; Vittorio Sciruicchio; Paolo Taurisano; Francesca Morgante; Elena Salvatore; Isabella Pia Ferrara; Livio Clemente; Chiara Sorbera; Marina de Tommaso
Journal:  Brain Sci       Date:  2022-05-21

3.  Impaired modulation of pain in patients with postherpetic neuralgia.

Authors:  Gisele Pickering; Bruno Pereira; Elodie Dufour; Sylvie Soule; Claude Dubray
Journal:  Pain Res Manag       Date:  2014-01-14       Impact factor: 3.037

4.  Spinal cord atrophy in early Huntington's disease.

Authors:  Mark Mühlau; Christina Engl; Christine C Boucard; Paul Schmidt; Viola Biberacher; Isabel Görsch; Christian Sorg; Afra Wohlschläger; Claus Zimmer; Bernhard Hemmer; Adolph Weindl
Journal:  Ann Clin Transl Neurol       Date:  2014-03-24       Impact factor: 4.511

Review 5.  The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum.

Authors:  Serena Boccella; Ida Marabese; Francesca Guida; Livio Luongo; Sabatino Maione; Enza Palazzo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.